Insider · CIK 0001364846

Wendel Bruce

Reports to the SEC for 7 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001364846

Forms 4 and 5

Insider transactions

36 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-09	IBRXImmunityBio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+65.6K sh	—	—	65,600
2025-12-12	IBRXImmunityBio, Inc. · Stock Option (right to buy)A Award	Director	AAward	+146K sh	—	—	146,020
2023-01-27	GTBPGT Biopharma, Inc. · Option to purchase Common StockA Award	Director	AAward	+500K sh	—	—	500,000
2022-07-15	GTBPGT Biopharma, Inc. · Option to purchase Common StockA Award	Director	AAward	+50K sh	—	—	50,000
2022-07-15	GTBPGT Biopharma, Inc. · Option to purchase Common StockA Award	Director	AAward	+50K sh	—	—	50,000
2021-02-16	GTBPGT Biopharma, Inc.A Award	Director	AAward	+348K sh	—	—	352,655
2021-02-16	GTBPGT Biopharma, Inc. · Option to purchase Common StockA Award	Director	AAward	+50K sh	—	—	50,000
2020-12-22	GTBPGT Biopharma, Inc.P Purchase	Director	PPurchase	+1,374 sh	$8.87	+$12.2K	4,642
2020-12-22	GTBPGT Biopharma, Inc.P Purchase	Director	PPurchase	+441 sh	$8.73	+$3,849.93	5,083
2020-11-16	GTBPGT Biopharma, Inc.P Purchase	Director	PPurchase	+3,268 sh	$3.14	+$10.3K	3,268
2020-06-16	VSTMVerastem, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2019-06-21	VSTMVerastem, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2018-06-11	VSTMVerastem, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2017-06-13	VSTMVerastem, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+25K sh	—	—	25,000
2016-06-14	VSTMVerastem, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+50K sh	—	—	50,000
2010-10-15	Abraxis BioScience, Inc.Stock Option (Right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−2,121 sh	$2.51	−$5,323.71	0
2010-10-15	Abraxis BioScience, Inc.A Award	Director, Chief Executive Officer	AAward	+50K sh	—	—	119,784
2010-10-15	Abraxis BioScience, Inc.Stock Option (Right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−3,678 sh	$8.15	−$30K	0
2010-10-15	Abraxis BioScience, Inc.D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−120K sh	—	—	0
2010-10-15	Abraxis BioScience, Inc.Stock Option (Right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−138K sh	$33.21	−$4.59M	0
2010-10-15	Abraxis BioScience, Inc.Stock Option (Right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−10.6K sh	$7.41	−$78.6K	0
2010-10-15	Abraxis BioScience, Inc.Stock Option (Right to buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−4,242 sh	$1.12	−$4,751.04	0
2010-03-15	Abraxis BioScience, Inc.A Award	Director, Chief Executive Officer	AAward	+74.4K sh	—	—	77,611
2010-03-15	Abraxis BioScience, Inc.Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+138K sh	—	—	138,125
2010-03-01	Abraxis BioScience, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−367 sh	$32.67	−$12K	3,236
2010-01-15	Abraxis BioScience, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−239 sh	$41.17	−$9,839.63	3,603
2009-11-10	Abraxis BioScience, Inc.S Sale	Director, Chief Executive Officer	SSale	−797 sh	$35.42	−$28.2K	1,084
2009-03-02	Abraxis BioScience, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+920 sh	—	—	23,725
2009-03-02	Abraxis BioScience, Inc.Restricted Stock UnitsM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−920 sh	—	—	2,758
2009-03-02	Abraxis BioScience, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−329 sh	$58.54	−$19.3K	23,396
2009-02-03	Abraxis BioScience, Inc.A Award	Director, Chief Executive Officer	AAward	+1,446 sh	—	—	22,961
2009-02-03	Abraxis BioScience, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−156 sh	$70.40	−$11K	22,805
2009-02-03	Abraxis BioScience, Inc.Restricted Stock UnitsA Award	Director, Chief Executive Officer	AAward	+1,446 sh	—	—	1,446
2007-11-28	Abraxis BioScience, Inc.Stock Option (Right to Purchase)A Award	Director, Chief Executive Officer	AAward	+11.5K sh	—	—	11,507
2007-11-28	Abraxis BioScience, Inc.Stock Option (Right to Purchase)A Award	Director, Chief Executive Officer	AAward	+2,121 sh	—	—	2,121
2007-11-28	Abraxis BioScience, Inc.Stock Option (Right to Purchase)A Award	Director, Chief Executive Officer	AAward	+4,242 sh	—	—	4,242

Recent filings

Accepted (ET)
Jun 104
Wendel Bruce0001364846-26-000003
SEC(opens sec.gov)
Dec 164
Wendel Bruce0001364846-25-000007
SEC(opens sec.gov)
Feb 14
Wendel Bruce0001493152-23-003224
SEC(opens sec.gov)
Jul 194
Wendel Bruce0001493152-22-019871
SEC(opens sec.gov)
Oct 74
Wendel Bruce0001654954-21-010887
SEC(opens sec.gov)
Jun 184
Wendel Bruce0000904454-20-000411
SEC(opens sec.gov)
Jun 254
Wendel Bruce0001104659-19-037503
SEC(opens sec.gov)
Feb 135
Wendel Bruce0000904454-19-000227
SEC(opens sec.gov)
Jun 154
Verastem, Inc.0001104659-17-039560
SEC(opens sec.gov)
Jun 164
Verastem, Inc.0001104659-16-127794
SEC(opens sec.gov)
Oct 194
Wendel Bruce0001181431-10-051408
SEC(opens sec.gov)

Companies

Address

C/O IMMUNITYBIO, INC. 3530 JOHN HOPKINS COURT

SAN DIEGO, CA, 92121